Perrigo receives FDA approval for three new infant formulas
Allegan-based Perrigo Co. (Nasdaq: PRGO) has announced its infant formula division, Perrigo Nutritionals — the world's largest supplier of store brand infant formula — has FDA clearance to make three new infant formula products.
The new formulas are also compliant with the Codex Alimentarius Commission, established by the Food and Agriculture Organization of the United Nations and the World Health Organization, which sets international food standards, guidelines and codes of practice to protect the health of consumers and ensuring fair trade practices globally.
Perrigo Nutritionals will be producing these FDA-cleared Codex Stage 1 milk based infant formulas, Codex Stage 2 milk based infant formula and Codex Stage 2 milk-based infant formula, with ethyl vanillin flavoring, in its ISO 9001:2008 certified infant-formula facility in Vermont. Formerly owned by Wyeth and PBM Nutritionals, the facility has been producing infant formula for more than 25 years.
PBM Nutritionals, which was headquartered in Virginia, was the world’s largest manufacturer of infant formula for store brands when it was acquired by Perrigo in 2010 for $808 million.
“Perrigo Nutritionals will be producing these three Codex formulas for existing customers and intends to sell them to future customers in the Middle East, Africa and Latin America,” said Joseph C. Papa, Perrigo’s chairman, president and CEO.
He added that many international markets are requesting that infant formulas imported into their countries be cleared for the United States market by FDA and sold in the countries where they are manufactured.
“Our formulas have been nourishing millions of infants around the world, and we are pleased to meet this emerging need with these three new Codex infant formulas,” said Papa.